Cerus Corporation Celebrates World Blood Donor Day 2025
CONCORD, Calif.--(BUSINESS WIRE)--Cerus Corporation (Nasdaq: CERS) is proud to announce its celebration of World Blood Donor Day 2025.
In 2005, the World Health Assembly designated June 14th as World Blood Donor Day to recognize and thank blood donors across the world for their important contributions to the global blood supply. This year's theme, 'Give blood, give hope: together we save lives' is a reminder that hope is something we can all share. Cerus is proud to promote blood safety and expand donor eligibility, helping more people give, and more people receive the transfusions they need. The Company salutes the individuals, communities, and countries working together to make blood safety and availability a reality.
'A safe and reliable blood supply remains a cornerstone of every effective healthcare system around the globe, and one that would not be possible without the countless individuals that donate their time and blood. World Blood Donor Day is an opportunity to thank these individuals and to raise public awareness of the ongoing need for additional blood donations,' said Obi Greenman, Cerus' President and Chief Executive Officer. 'I am proud that Cerus is leading the development of pathogen reduction technologies for transfused blood components to help enable our blood center customers to deliver safe and effective blood components to patients.'
According to the World Health Organization (WHO), more than 118.5 million blood donations are collected annually around the world, with 40% of these donations collected in high-income countries that account for only 16% of the global population. A wide variety of patients regularly receive blood transfusion, including cardiovascular surgery, transplant surgery, massive trauma, cancer, obstetric, and childhood anemia patients. 1
In recognition of World Blood Donor Day, Cerus hosted a blood drive earlier this week at its company headquarters and encourages everyone to participate in supporting blood product availability in their local communities.
1. https://www.who.int/news-room/fact-sheets/detail/blood-safety-and-availability
ABOUT CERUS
Cerus Corporation is dedicated solely to safeguarding the world's blood supply and aims to become the preeminent global blood products company. Headquartered in Concord, California, the company develops and supplies vital technologies and pathogen-protected blood components to blood centers, hospitals, and ultimately patients who rely on safe blood. The INTERCEPT Blood System for platelets and plasma is available globally and remains the only pathogen reduction system with both CE mark and FDA approval for these two blood components. In the U.S., the INTERCEPT Blood System for Cryoprecipitation is approved for the production of Pathogen Reduced Cryoprecipitated Fibrinogen Complex (commonly referred to as INTERCEPT Fibrinogen Complex), a therapeutic product for the treatment and control of bleeding, including massive hemorrhage, associated with fibrinogen deficiency. The INTERCEPT red blood cell system is under regulatory review in Europe, and in late-stage clinical development in the U.S. For more information about Cerus, visit www.cerus.com and follow us on LinkedIn.
INTERCEPT and the INTERCEPT Blood System are trademarks of Cerus Corporation.
Hashtags
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Yahoo
2 hours ago
- Yahoo
Should You Buy Nvidia Before June 25? Here's What History Says (and It May Surprise You).
Artificial intelligence (AI) powerhouse Nvidia recently impressed investors with soaring revenue that beat analysts' estimates. The stock climbed in the weeks following the report. Investors are closely watching Nvidia CEO Jensen Huang's comments about future prospects for the company and the general AI market. 10 stocks we like better than Nvidia › Nvidia (NASDAQ: NVDA) has been one of the stock market's biggest movers and shakers in recent times. This is because the company plays a key role in a technology that has garnered everyone's attention: artificial intelligence (AI). Nvidia's chips power the training of models that set AI into action, and AI could change the world in much the same way the internet did several years ago. That's why investors have piled into Nvidia stock and have closely tuned in to anything the company's chief executive officer Jensen Huang has said. These comments offer us some visibility on what's ahead for the company -- and even the entire industry. So, it's not surprising that, often, after an Nvidia event, the stock will react. As we look at the calendar, it tells us that one such event is right around the corner. On June 25, Nvidia holds its annual meeting of stockholders. Should you buy the stock before then? History has something to say -- and it may surprise you. Before we get started, let's talk about Nvidia's most recent big moment, and that was the company's first-quarter earnings report on May 28. Nvidia wowed investors once again, as revenue soared 69% to more than $44 billion, surpassing analysts' estimates -- and importantly, the company spoke of ongoing strong demand for its new Blackwell architecture. The platform was designed specifically with inferencing in mind, a smart move considering that is the area of focus for many AI customers. Inferencing is the "thinking" process that results in AI coming up with answers to complex questions, and this requires significant power. "We're off to the races," Huang said during the earnings call, signaling much more growth lies ahead. Nvidia stock climbed in the post-earnings trading session, and though it fluctuated on certain trading days, it delivered a gain of about 6% in the two weeks following the report. Now, let's consider the upcoming shareholders' meeting. The company recently released the agenda, which includes items of business such as the election of directors nominated by the board of directors, advisory approval of executive compensation, and several other matters. These don't stand out as elements that will push the stock higher or lower, though any comments from Huang about the company's prospects could act as a catalyst. What does history show us about Nvidia's stock performance after a shareholders' meeting? As the chart shows, the stock fell in the days following last year's meeting, then went on to rebound in the weeks to follow. Nvidia followed a similar pattern in 2023. And in 2022, the stock also fell following the meeting, but didn't go on to recover so quickly -- in fact, Nvidia delivered a double-digit loss from that point through the end of the year. So it might seem surprising that, in spite of Nvidia's earnings and general message being positive over the past few years, the stock actually fell after each shareholder meeting. It's important to keep in mind, though, that this likely isn't a result of anything said or decided at the annual event. At this point in Nvidia's growth story, investors react to new or extremely strong messages from Huang -- but they may not reward the stock with gains after a "routine" sort of event such as a shareholder meeting. Now let's get back to our question: Should you buy Nvidia before June 25? History tells us there's no need to rush into the stock on anticipation of phenomenal gains following the shareholder meeting. But this doesn't mean Nvidia isn't a buy. The company has built a market-leading position and should maintain this thanks to its commitment to innovation. That makes Nvidia stock a fantastic addition to any AI portfolio, but you don't have to rush into it -- whether you buy Nvidia now or after the meeting, you have a great chance of winning over the long haul. Before you buy stock in Nvidia, consider this: The Motley Fool Stock Advisor analyst team just identified what they believe are the for investors to buy now… and Nvidia wasn't one of them. The 10 stocks that made the cut could produce monster returns in the coming years. Consider when Netflix made this list on December 17, 2004... if you invested $1,000 at the time of our recommendation, you'd have $653,702!* Or when Nvidia made this list on April 15, 2005... if you invested $1,000 at the time of our recommendation, you'd have $870,207!* Now, it's worth noting Stock Advisor's total average return is 988% — a market-crushing outperformance compared to 172% for the S&P 500. Don't miss out on the latest top 10 list, available when you join . See the 10 stocks » *Stock Advisor returns as of June 9, 2025 Adria Cimino has no position in any of the stocks mentioned. The Motley Fool has positions in and recommends Nvidia. The Motley Fool has a disclosure policy. Should You Buy Nvidia Before June 25? Here's What History Says (and It May Surprise You). was originally published by The Motley Fool 擷取數據時發生錯誤 登入存取你的投資組合 擷取數據時發生錯誤 擷取數據時發生錯誤 擷取數據時發生錯誤 擷取數據時發生錯誤
Business Wire
3 hours ago
- Business Wire
FinTech Leader Kennel Connection Launches Enhanced Report Cards to Help Pet Care Pros Save Time and Build Trust
MOORPARK, Calif.--(BUSINESS WIRE)--Kennel Connection, a leader in pet care management software and a 100GROUP company, is proud to announce a comprehensive update to its Report Cards feature, a powerful and modernized communication tool designed to help pet care businesses deliver personalized updates to clients with ease. 'This new version of Report Cards helps businesses deliver meaningful updates without slowing down their day.' — Jeff Brodsly, CEO While report cards have long been part of the Kennel Connection experience, this major overhaul introduces a redesigned interface, enhanced functionality, and new delivery options that make the system more powerful and user-friendly than ever. Built for daycare, boarding, and special services, the revamped Report Cards feature allows pet care facilities to share structured, customized updates via email or SMS in just a few clicks. Staff can quickly add notes about a pet's behavior, eating habits, elimination, and playtime by selecting from pre-written messages or adding their own touch. The addition of optional pet photos brings each update to life, helping clients feel connected to their pet's stay while reinforcing trust in the business. Users can now choose from a variety of sleek, professionally designed templates that reflect the modern pet care experience. Whether you're aiming for playful and colorful or clean and minimalist, there's a layout to match your brand and client preferences, offering both visual polish and practical customization. A Streamlined Workflow with a Personal Touch With Report Cards, pet care teams can create and send professional, mobile-friendly updates directly from the appointment screen, dashboard, pet card, client card, or schedule. Each report card can be sent once for the full stay or as a daily summary, allowing businesses to tailor the frequency and content to their preferred workflow. Key capabilities of the revamped Report Cards feature include: Customizable sections for behavior, meals, elimination, and playtime Flexible messaging options including rotating text templates and editable notes Quick delivery via email or text with the option to include pet photos Preview and edit tools for enhanced control and personalization Multiple clean, modern templates to choose from, allowing alignment with business branding "Client communication is at the heart of any successful pet care operation," said Jeff Brodsly, Owner and CEO of Kennel Connection and 100GROUP. "This new version of Report Cards helps businesses deliver meaningful updates without slowing down their day. It's about giving pet parents peace of mind while making it easier for teams to stay efficient and consistent." Part of a Broader Vision The update of Report Cards aligns with Kennel Connection's ongoing commitment to innovation, efficiency, and customer satisfaction. As part of its growing suite of tools, including integrated credit card processing, digital contracts, advanced booking, and text-to-pay, Report Cards further supports pet care businesses in delivering a seamless and modern client experience. About Kennel Connection: Kennel Connection is a leading provider of innovative software solutions for pet care businesses, offering a comprehensive suite of management tools designed to streamline operations and enhance customer experience. With a focus on empowering pet care professionals, Kennel Connection's feature-rich platform encompasses reservation management, client communication, billing, and reporting, alongside innovative features such as Text-To-Pay, digital contracts, advanced online booking, and integrated credit card processing; all aimed at driving efficiency and organization in day-to-day operations. Kennel Connection leverages cutting-edge technology to deliver tailored solutions that cater to the unique needs of pet care providers nationwide. For more information about Kennel Connection, visit
Yahoo
4 hours ago
- Yahoo
1 Beaten-Down Stock Down 99% That's Still Not Worth Buying
Canopy Growth has lost almost all of its market value in the past five years. The company's prospects remain dim, and its financial results are unimpressive. There's hardly any good reason to expect the stock to recover. 10 stocks we like better than Canopy Growth › Canopy Growth (NASDAQ: CGC) emerged as a leader in the cannabis industry when Canada legalized recreational, adult use of the substance in 2018. Investors had high hopes for the company and the rest of the market but, unfortunately, these hopes have now evaporated. Over the past five years, Canopy Growth has lost 99% of its value, and the company's shares now trade for under $2 apiece. Yet the stock remains unattractive. Here's why. Canopy Growth has a deep footprint in the Canadian cannabis market, encompassing both recreational and medical sectors, but the company's business extends far beyond this neighbor to the north. The pot grower has significant international operations, notably through Storz & Bickel, a subsidiary that manufactures and markets vape devices in various countries. Canopy Growth's suite of products spans dried flower, vapes, pre-rolls, oils, cannabis-infused drinks, and more. Despite having a significant worldwide footprint and a vast portfolio, the company has faced substantial headwinds. The cannabis market remains severely regulated, even in Canada, where laws are more lax. Never mind in other countries like the U.S., where the substance remains illegal at the federal level. Further, the perception that the pot market would become far more lucrative following Canada's decision to legalize weed created a bit of a gold rush, leading to stiff competition and oversupply problems in the market. Although Canopy Growth remained one of the more notable players throughout all this, that's not saying much, considering how poorly the industry has performed over the past five years. Meanwhile, the company's financial results remain horrendous. On May 30, Canopy Growth reported its financial results for the fourth quarter of its fiscal year 2025, ending on March 31. Though the company's cannabis revenue in Canada increased by 4% year over year, Canopy Growth's net revenue was 65 million Canadian dollars, down 11%, compared to the year-ago period. The pot grower's performance in international markets negatively impacted its overall performance. Elsewhere, Canopy Growth remains deeply unprofitable. Its net loss per share for the period was CA$1.43, much worse than the CA$1.03 loss per share it reported in the year-ago period. Canopy Growth tried to put a positive spin on its financial results. It pointed to its decreasing total debt by 49% during its fiscal year 2025. The pot grower continues to try to cut costs and improve profitability. Management also expects to reach positive adjusted earnings before interest, taxes, depreciation, and amortization (EBITDA) in "the near term" and to become free-cash-flow positive "over time." Bulls could point to potential long-term opportunities, as Canopy Growth has a presence in the U.S. cannabis market. If the substance does become legal at the federal level in the country, it could hit the ground running and become a leader in what would be the largest marijuana market in the world. However, investors shouldn't fall for it. Canopy Growth's goal to reach positive adjusted EBITDA in the "near term" is just hopeful enough and vague enough to be materially meaningless for the purposes of rendering its prospects more attractive. Even if it does achieve that goal, that still wouldn't make it profitable on an adjusted basis, let alone on a generally accepted accounting principles (GAAP) basis. Maybe that wouldn't be a massive issue if Canopy Growth was growing its revenue at a good clip. Plenty of companies that are reporting losses on the bottom line can be attractive investments, but there's little else going in Canopy Growth's favor to justify buying the stock right now. No one can predict when or whether pot will become legal at the federal level in the U.S. Even if it does, that might not solve the company's issues, the same way regulatory progress in Canada didn't lead to automatic success. In short, even if its stock is trading below $2 per share, Canopy Growth doesn't look like an attractive stock to buy. Investors should steer clear of the company. Before you buy stock in Canopy Growth, consider this: The Motley Fool Stock Advisor analyst team just identified what they believe are the for investors to buy now… and Canopy Growth wasn't one of them. The 10 stocks that made the cut could produce monster returns in the coming years. Consider when Netflix made this list on December 17, 2004... if you invested $1,000 at the time of our recommendation, you'd have $653,702!* Or when Nvidia made this list on April 15, 2005... if you invested $1,000 at the time of our recommendation, you'd have $870,207!* Now, it's worth noting Stock Advisor's total average return is 988% — a market-crushing outperformance compared to 172% for the S&P 500. Don't miss out on the latest top 10 list, available when you join . See the 10 stocks » *Stock Advisor returns as of June 9, 2025 Prosper Junior Bakiny has no position in any of the stocks mentioned. The Motley Fool has no position in any of the stocks mentioned. The Motley Fool has a disclosure policy. 1 Beaten-Down Stock Down 99% That's Still Not Worth Buying was originally published by The Motley Fool Error in retrieving data Sign in to access your portfolio Error in retrieving data Error in retrieving data Error in retrieving data Error in retrieving data
